PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee YJ et al. - The authors demonstrated weekly 5-FU-cisplatin with conventional radiotherapy was efficacious and feasible with high compliance rate in locally advanced head and neck cancer.

Related Articles

Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09    Relevance Score: 71%

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09    Relevance Score: 71%

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09    Relevance Score: 69%

Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09    Relevance Score: 69%

Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09    Relevance Score: 69%

Today in ENT...keeping you current

Neural response thresholds in the Nucleus Contour cochlear implant before and after stylet removal
Acta Oto-Laryngologica , 12/03/09

Effects of topical drops and sprays on mucociliary transport time and nasal air flow
Acta Oto-Laryngologica , 12/03/09

Pressure changes in the human middle ear without opening the eustachian tube
Acta Oto-Laryngologica , 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address